2 completed, 1 enrolling by invitation. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Enrolling by invitation 1 |
| Phase 1 | 1 | Enrolling by invitation 1 |
| Phase 3 | 1 | Completed 1 |
Follow Exfoliation Syndrome: new trials by email Literature Review of Exfoliation Syndrome trials Research Report on Exfoliation Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical Insulin for Glaucoma (TING2) EYED-002 Low Dose (721 U/mL topical insulin), EYED-002 High Dose (1442 U/mL topical insulin), EYED-002 (highest tolerated dose, 12-month) - Open Angle Glaucoma, Primary Open Angle Glaucoma | Phase 1 / Phase 2 | Enrolling by invitation | Stanford University | 90 | 2026-09-10 | 2026-10-13 |
| A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma AR-12286 - Exfoliation Syndrome, Ocular Hypertension | Phase 2 | Completed | Robert Ritch, MD, LLC. | 10 | 2013-09-01 | 2018-11-16 |
| Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery? Triesence, balanced salt solution BSS - Glaucoma | Phase 2 / Phase 3 | Completed | Wills Eye | 77 | 2009-02-01 | 2018-07-10 |
Glaucoma, Open-Angle (3) · Glaucoma (2) · Glaucoma, Angle-Closure (1) · Glaucoma, Neovascular (1) · Low Tension Glaucoma (1) · Ocular Hypertension (1)
Eye Diseases (3) · Iris Diseases (3) · Uveal Diseases (3) · Ocular Hypertension (2) · Glaucoma (1) · Optic Nerve Diseases (1)
AR-12286 (1) · Hanks Balanced Salt Solution (1) · Insulin (1) · Triamcinolone (1)
Robert Ritch, MD, LLC. (1) · Stanford University (1) · Wills Eye (1)
United States (3)
Jeffrey L Goldberg, MD PhD (1) · Marlene R Moster, MD (1)